Endoscopic hemostasis

Nexpowder™* endoscopic hemostasis system

<p>The Nexpowder™* endoscopic hemostasis system delivers a hemostatic adhesive powder for the management of refractory and active GI bleeding sites.</p>

Ordering information

Contact a representative

Indications, Safety, and WarningsThe material on this website should not be considered the exclusive source of information, it does not replace or supersede information contained in the device manual(s).Please note that the intended use of a product may vary depending on geographical approvals.See the device manual(s) for detailed information regarding the intended use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events.For a MRI compatible device(s), consult the MRI information in the device manual(s) before performing a MRI.If a device is eligible for eIFU usage, instructions for use can be found at the Medtronic website manuals.medtronic.com.Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.Medtronic products placed on European markets comply with EU and UK legislation (if applicable) on medical devices. For any further information, contact your local Medtronic representative.Medtronic medical devices marketed in Spain are in compliance with the Spanish legislation in force.

Features

Benefits of the Nexpowder™* endoscopic hemostasis system

A proprietary powder coating technology that minimizes catheter clogging and particle scattering^1,2
Innovative delivery system that doesn’t rely on carbon dioxide or additional air compressors^1,2,4,5
Distinctive blue color so you can have the confidence the lesion is fully covered^1,5
Highly adhesive gel that reacts to moisture, not just active bleeding, so it can be used in a variety of clinical applications^1,2,4

Clinical evidence

Efficacy of a novel hemostatic adhesive powder in patients with upper gastrointestinal tumor bleeding

Authors: Jongbeom Shin et al.
Published in: BMC Gastroenterol (2021) 21:40

Conclusion: In conclusion, this single-arm study demonstrated Nexpowder™* was associated with excellent immediate hemostasis rate and safety profile as well as low rebleeding for upper gastrointestinal tumor bleeding.

Download the clinical summary (open in new window)

Nexpowder™* clinical cases video

Ordering information

Item number	Description	Units per box
NHS03	Nexpowder™* endoscopic hemostasis system	1

European Esophageal Product Family brochure,EMEA-SE-2100161 - 21-weu-esophageal-product-family-brochure-5632155, EMEA‑SE‑2100161-esophageal-product-family-brochure-en-we-8899883

Esophageal product family brochure (open in new window)

View a sales tool brochure for healthcare professionals presenting the esophageal and gastric portfolio with new messages regarding transforming esophageal care and endoscopy.

PRODUCT PDF 2 MB

Nexpowder™* endoscopic hemostasis system

Features

Benefits of the Nexpowder™* endoscopic hemostasis system

Clinical evidence

Efficacy of a novel hemostatic adhesive powder in patients with upper gastrointestinal tumor bleeding

Nexpowder™* clinical cases video

Ordering information

Related links

Capsule Endoscopy System Tech Support Promo Box

Technical support